Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers

IMPORTANCE: Prophylactic bilateral salpingo-oophorectomy is recommended for BRCA1 mutation carriers to prevent ovarian cancer. Whether or not hormone replacement therapy (HRT) initiated after oophorectomy is associated with an increased risk of breast cancer has not been evaluated in a prospective s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Autores principales: Kotsopoulos, Joanne, Gronwald, Jacek, Karlan, Beth Y., Huzarski, Tomasz, Tung, Nadine, Moller, Pal, Armel, Susan, Lynch, Henry T., Senter, Leigha, Eisen, Andrea, Singer, Christian F., Foulkes, William D., Jacobson, Michelle R., Sun, Ping, Lubinski, Jan, Narod, Steven A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143051/
https://ncbi.nlm.nih.gov/pubmed/29710224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.0211
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares